Work

Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx376.045

Authors: P.S. Stanczak, M.M. Grzybowski, P. Wolska, A.M. Zdziarska, M. Mazurkiewicz, R. Blaszczyk, J. Nowicka, A. Sosnowska, K. Ramji, D. Nowis, J. Golab, A. Golebiowski, P. Dobrzanski, K. Dzwonek

Institutions: OncoArendi Therapeutics (Poland), Medical University of Warsaw, University of Warsaw

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Bristol-Myers Squibb

OpenAlex ID: W2762932397

FWCI: 0.785

Cites:

Cited by: 10

Related to: 10